MedicalResearch.com Interview with:
Genevieve P. Kanter, PhD
Assistant Professor (Research) of Medicine
Medical Ethics and Health Policy
University of Pennsylvania Perelman School of Medicine
MedicalResearch.com: What is the background for this study?
Response: In 2010, the US Congress—concerned about the adverse influence of financial relationships between physicians and drug and device firms, and the lack of transparency surrounding these relationships—enacted the Physician Payments Sunshine Act. This legislation required pharmaceutical and medical device firms to report, for public reporting through the Open Payments program, the payments that these firms make to physicians.
We sought to evaluate the effect of Open Payments’ public disclosure of industry payments information on US adults’ awareness of the issue of industry payments and knowledge of whether their physicians’ had received industry payments.
MedicalResearch.com: What are the main findings?
Response: Using a difference-in-difference strategy, we found no effect of Open Payments on patients’ awareness of the issue of industry payments, but we did find an increase (of 10 percentage points) in awareness that payments information was publicly available.
Open Payments did not, however, increase the percentage of patients who knew whether their own physician had received industry payments. Two years after the release of industry payments information, only 3% of US adults knew whether physician had received an industry payment.
MedicalResearch.com: What should readers take away from your report?
Response: The Physician Payment Sunshine Act appears to be far from achieving its goal of increasing patient engagement with the issue of industry payments. Efforts beyond the unveiling of a public website will be required to increase patients’ knowledge and awareness of their physicians’ interactions with industry.
MedicalResearch.com: What recommendations do you have for future research as a result of this work?
Response: Future research should investigate how the government can support transparency efforts and increase patient engagement with the issue of industry payments.
Kanter GP, Carpenter D, Lehmann L, et al
BMJ Open 2019;9:e024020. doi: 10.1136/bmjopen-2018-024020
The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.